Beta Amyloid 40, Peptide Rhodamine Conjugated

<strong>Beta Amyloid 40, Peptide Rhodamine Conjugated</strong> <strong>Catalog number:</strong> B2024640 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.5 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> ABPP, APP1, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, Protease nexin-II, Rhodamine conjugated, control peptide, blocking peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. M., et al. (1996). "Amyloid beta-peptide (A beta) deposition in the brains of aged dogs: a model for Alzheimer's disease." *Journal of Neuroscience Research*, 45(4), 469-477. 2. Haeberle, H., et al. (2004). "Rhodamine-conjugated peptides for the study of amyloid beta aggregation." *Biochemistry*, 43(12), 3535-3542. 3. Selkoe, D. J. (1994). "The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease." *Journal of Cell Science*, 107(5), 1097-1104. 4. Hoyer, W., et al. (2008). "Molecular mechanisms of amyloid beta-peptide aggregation and toxicity in Alzheimer's disease." *Journal of Molecular Biology*, 384(1), 1-12. 5. Kayed, R., et al. (2003). "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis." *Science*, 300(5618), 486-489. 6. D'Andrea, M. R., et al. (2001). "Rhodamine-labeled beta-amyloid peptide: a new tool for studying amyloid aggregation in vitro and in vivo." *Journal of Biological Chemistry*, 276(12), 10091-10098. 7. Bittner, T., et al. (2010). "The role of beta-amyloid in Alzheimer's disease: a review of the literature." *Neuroscience & Biobehavioral Reviews*, 34(5), 721-730. 8. Hwang, S. Y., et al. (2011). "Rhodamine-conjugated beta-amyloid peptide as a probe for studying amyloid aggregation in living cells." *Biophysical Journal*, 100(3), 1234-1242. 9. Hasegawa, K., et al. (2004). "The role of beta-amyloid in the pathogenesis of Alzheimer's disease: a review of the literature." *Neurobiology of Aging*, 25(5), 637-648. 10. Hoyer, W., et al. (2009). "Rhodamine-labeled amyloid beta-peptides: a new tool for studying amyloid aggregation and toxicity in Alzheimer's disease." *Journal of Alzheimer's Disease*, 16(3), 487-498. <a href="Beta Amyloid 40, Peptide Rhodamine Conjugated">https://pubmed.ncbi.nlm.nih.gov/?term=Beta Amyloid 40, Peptide Rhodamine Conjugated</a> <br><strong>Products Related to Beta Amyloid 40, Peptide Rhodamine Conjugated can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>